Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
1.300
+0.100 (8.33%)
At close: Dec 19, 2025
Cresco Labs Market Cap
Cresco Labs has a market cap or net worth of $455.92 million as of December 19, 2025. Its market cap has increased by 19.12% in one year.
Market Cap
455.92M
Enterprise Value
908.01M
Revenue
661.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.30
Market Cap Chart
Since December 3, 2018, Cresco Labs's market cap has decreased from 627.84M to 455.92M, a decrease of -27.38%. That is a compound annual growth rate of -4.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 455.92M | 42.47% |
| Dec 31, 2024 | 320.01M | -30.65% |
| Dec 29, 2023 | 461.48M | -15.53% |
| Dec 30, 2022 | 546.30M | -71.66% |
| Dec 31, 2021 | 1.93B | -17.69% |
| Dec 31, 2020 | 2.34B | 148.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 832.80M |
| Glass House Brands | 766.54M |
| Elite Pharmaceuticals | 537.07M |
| CytoDyn | 398.68M |
| Northwest Biotherapeutics | 374.98M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 198.84M |